AAPG — Ascentage Pharma Group International
Ascentage Pharma Group International trades under the ticker AAPG on NASDAQ.
Its activity is classified under HEALTHCARE, in the BIOTECHNOLOGY industry.
Searching for the Ascentage Pharma Group International share price, or whether to buy AAPG? This page brings together a live chart, momentum and risk scores, fresh news and community sentiment.
VAQO runs a statistical model over AAPG that reads seven technical indicators and translates them into an opportunity score and a risk score — including which factors drove them.
What AAPG is
Ascentage Pharma Group International, a clinical-stage biotechnology company, develops therapies for cancers, chronic hepatitis B virus (HBV), and age-related diseases in Mainland China. The company is headquartered in Suzhou, China.…
Ascentage Pharma Group International is classified under HEALTHCARE, in the BIOTECHNOLOGY industry.
It trades on NASDAQ as a common stock.
AAPG size and valuation
At roughly $1.50B, AAPG is a small-cap.
Earnings per share are negative at -2.26, so there is no meaningful price-to-earnings multiple to quote.
Beta is 0.66: historically it has moved less than the market.
AAPG over the past year
Over the past year AAPG has traded between $14.54 and $38.58, and the current price sits at 4% of that range.
Trading near the low end of a 52-week range is a different situation from a bad day: it means the year, not the session, has gone against it.
The 50-day average is $16.98 against a 200-day average of $21.32 — the shorter average sits below the longer one, usually read as a downtrend.
The published analyst target is $47.12, 205.4% above it. A target is an aggregate of opinions, not a measurement.
How Ascentage Pharma Group International (AAPG) is trading
Ascentage Pharma Group International (AAPG) is up 2.46% at $15.43 — a more volatile session than average.
The session ranged from $15.05 to $15.50 — 2.9% of the share price — and the current price sits at 84% of that range.
It opened at 18% of the daily range and finished at 84% of it: AAPG turned around inside the session, in the buyers' favour.
Volume ran near 5.5K shares, about $85.5K of stock changing hands.
Traded alongside AAPG
Names traded alongside AAPG in the same sector: A (Agilent Technologies Inc), AARD (Aardvark Therapeutics Inc), ABCL (AbCellera Biologics Inc), ABEO (Abeona Therapeutics Inc), ABOS (Acumen Pharmaceuticals Inc).
What VAQO's model says about AAPG
Two statistical models run over AAPG inside the browser, reporting momentum, risk and opportunity separately. Full accuracy for both, including when it falls, is published on the model page.
Key facts
- Symbol: AAPG
- Name: Ascentage Pharma Group International
- Sector: HEALTHCARE
- Industry: BIOTECHNOLOGY
- Exchange: NASDAQ
- Instrument: Stock
AAPG — frequently asked questions
What is the market cap of AAPG?
Ascentage Pharma Group International has a market capitalisation of roughly $1.50B.
What is the 52-week range for AAPG?
AAPG has traded between $14.54 and $38.58 over the past year, with the current price at 4% of that range.
How much does AAPG stock cost today?
Ascentage Pharma Group International (AAPG) trades at $15.43, a change of +2.46% in the latest session.
Is AAPG up or down today?
AAPG is up 2.46% in the latest session, at $15.43.
What is the daily trading range for AAPG?
AAPG traded between $15.05 and $15.50 in the latest session, and currently trades at $15.43.
What is the trading volume for AAPG?
AAPG traded roughly 5.5K shares in the latest session.
Which exchange is AAPG listed on?
AAPG is listed on NASDAQ, in the HEALTHCARE sector.
Should I buy AAPG stock?
VAQO gives no buy or sell recommendations and is not an investment adviser. The AAPG figures on this page — price, range, volume and the model's scores — are there to inform your decision, not to stand in for it.
Others in HEALTHCARE
- A — Agilent Technologies Inc
- AARD — Aardvark Therapeutics Inc
- ABCL — AbCellera Biologics Inc
- ABEO — Abeona Therapeutics Inc
- ABOS — Acumen Pharmaceuticals Inc
- ABSI — Absci Corp
Last updated: 2026-11-08